⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1902282 | 0.73 | — | — | |
| SCHEMBL14733244 | 0.67 | — | — | |
| SCHEMBL22821938 | 0.67 | — | — | |
| SCHEMBL1558625 | 0.67 | — | — | |
| SCHEMBL9302491 | 0.65 | — | — | |
| SCHEMBL10001288 | 0.64 | — | — | |
| SCHEMBL8717250 | 0.62 | — | — | |
| SCHEMBL10038362 | 0.62 | — | — | |
| SCHEMBL8720180 | 0.62 | — | — | |
| SCHEMBL9302527 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101605-A1 | ELECTROLYTE FOR ELECTROCHEMICAL NITROGEN REDUCTION REACTION AND METHOD FOR ELECTROCHEMICALLY PREPARING AMMONIA USING THE SAME | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2025-03-27 | — | — | US | claimed |
| CN-118239923-A | Compounds useful as inhibitors of factor XIIa, pharmaceutical compositions and uses thereof | 合肥工业大学 | 2024-06-25 | — | — | CN | claimed |
| US-20240105998-A1 | HIGH ENERGY METAL SULFUR OR SELENIUM-SULFUR BATTERY | UCHICAGO ARGONNE, LLC (US) | 2024-03-28 | — | — | US | claimed |
| US-11769905-B2 | Poly(alkylene oxide) siloxane-based electrolytes for rechargeable batteries | UCHICAGO ARGONNE, LLC (US) | 2023-09-26 | — | — | US | claimed |
| US-20230100910-A1 | NON-FLAMMABLE ELECTROLYTES | UCHICAGO ARGONNE, LLC (US) | 2023-03-30 | — | — | US | claimed |
| CN-113620925-B | Synthetic method of fluorine-containing monomer 2, 2-difluoro-4, 5-bis (trifluoromethyl) -1, 3-dioxyheterocycle | 四川轻化工大学 | 2022-04-15 | — | — | CN | claimed |
| CN-110003165-B | Synthesis method of chloro-2, 2-di (perfluorinated substituent) -1, 3-dioxolane compound | 浙江省化工研究院有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-106459020-B | Amino ester derivatives | 奇斯药制品公司 | 2019-06-18 | — | — | CN | claimed |
| US-10239882-B2 | Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2019-03-26 | — | — | US | claimed |
| US-20190044181-A1 | POLY(ALKYLENE OXIDE) SILOXANE-BASED ELECTROLYTES FOR RECHARGEABLE BATTERIES | UNITED STATES DEPARTMENT OF ENERGY | 2019-02-07 | — | — | US | claimed |
| US-20110003845-A1 | SUBSTITUTED AZABICYCLIC COMPOUNDS AND THE USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2011-01-06 | — | — | US | claimed |
| EP-2235011-A1 | SUBSTITUTED PYRROLO[2, 3-B]AND PYRAZOLO[3, 4-B]PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-10-06 | — | — | EP | claimed |
| EP-2234980-A1 | FUSED CYNOPRYRIDINES AND THE USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-10-06 | — | — | EP | claimed |
| WO-2009143992-A1 | 2-ALKOXY-SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-12-03 | — | — | WO | claimed |
| WO-2009080197-A1 | SUBSTITUTED PYRROLO[2, 3-B] AND PYRAZOLO[3, 4-B] PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080198-A1 | FUSED CYNOPRYRIDINES AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | WO | claimed |
| US-20080300232-A1 | N-Piperidine Derivatives as Ccr3 Modulators | ASTRAZENECA AB (SE) | 2008-12-04 | — | — | US | claimed |
| EP-1953147-A1 | HETEROCYCLIC COMPOUND AND MEDICINAL APPLICATION THEREOF | Japan Tobacco, Inc. (JP) | 2008-08-06 | — | — | EP | claimed |
| EP-1730136-A1 | N-PIPERIDINE DERIVATES AS CCR3 MODULATORS | AstraZeneca AB (SE) | 2006-12-13 | — | — | EP | claimed |
| WO-2005090330-A1 | N-PIPERIDINE DERIVATES AS CCR3 MODULATORS | ASTRAZENECA AB (SE) | 2005-09-29 | — | — | WO | claimed |